Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03333343
Title Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA | DEU | CAN

Facility Status City State Zip Country Details
Novartis Investigative Site Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site Essen 45147 Germany Details
Novartis Investigative Site Koeln 50937 Germany Details
Novartis Investigative Site Shatin New Territories Hong Kong Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 168583 Singapore Details
Novartis Investigative Site Tainan 70403 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field